Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.
|
June 16, 2011
|
June 8, 2011
|
June 6, 2011
|
June 3, 2011
|
|
June 3, 2011
|
June 2, 2011
|
June 1, 2011
|
May 31, 2011
|